-
MD Anderson Launches Gamma-Delta T-Cell Therapy Study, New Multi-Year Multi-Omics Cancer Resistance Mechanisms Research, More
Jan 26 | Clinical Research News | A major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in multiple cancer types; the first one-stop-shop decentralized clinical trial platform bundled with site and trial execution services for the digital therapeutics market; a unique and unparalleled suite of early to late-phase CRO services across Europe, the US, and Asia Pacific; and more. More -
Follow the Money: PCORI Opens Nine Research Funding Opportunities, Novel Transcriptome-Wide Profiling Research, More
Jan 24 | Clinical Research News | Funding for preclinical development and clinical proof-of-concept therapeutic studies, comparative clinical effectiveness research to help patients and other stakeholders make better-informed health choices, clinical decision support expansion for diagnostic and surveillance tools, and more. More -
Revolutionizing Payment Products is Vital for Increasing Clinical Trial Participant Satisfaction and Diversity
Jan 20 | Clinical Research News | Patient-centricity has become a buzzword in clinical trials, but many practical barriers still limit diversity and reduce participant satisfaction. As an industry, our true north should be making it easier to participate in clinical trials for a meaningful impact on patients and significant added value for sponsors. More -
Retinal Organoid-Derived Neurons to Potentially Cure Degenerative Eye Disease
Jan 18 | Clinical Research News | A new study published in the Proceedings of the National Academy of Science demonstrates the potential for lab-grown retinal neurons to reestablish synaptic function and cure neurodegenerative eye disease, according to researchers from the University of Wisconsin–Madison. More -
Improving Pediatric Clinical Trial Development in 2023
Jan 13 | Clinical Research News | A clinical trial’s path from initial design to completion is exceptionally complex. Poor patient recruitment and low retention rates complicate the clinical trial process, especially in studies for children with rare diseases. Thankfully, patient concierge services will offer immense insight into the unique support needs of individual pediatric patients and their families and increase the success rates for life-saving treatments. More -
Virtual Site Brings Speed, Diversity, And Engagement To Digital Therapeutic Trial
Jan 11 | Clinical Research News | Digital therapeutics are a natural fit with the decentralized clinical trial model and the COVID-19 pandemic has been a major driver of demand for both. The hybrid-designed PROSPER-FM trial is a good case in point. The devices being studied are a digital Acceptance and Commitment Therapy program and digital symptom tracker for adults with fibromyalgia and the single virtual site, run by Curavit, has been enrolling 10 times more patients than all other bricks-and-mortar sites starting at the same time. More -
SCOPE Preview: Patient-Centricity, Real-World Evidence, and the Evolution of Clinical Trial Design
Jan 10 | Clinical Research News | Clinical Research News will be attending the Summit for Clinical Ops Executives—SCOPE—in Orlando, Fla. from February 6-9, 2023. Here are just a few of the items from the agenda we’ve flagged so far. More
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.
